Article summary
- Understanding Chronic Rhinosinusitis (CRS) Diagnosis
- Transitioning from Medical Management to Surgical Options
- Functional Endoscopic Sinus Surgery (FESS): What to Expect
- The Role of Propel™ Sinus Implants in Surgical Recovery
- Balloon Sinus Surgery (BSS) vs. Traditional Endoscopic Methods
- Post-Operative Milestones and Long-Term Success
Understanding Chronic Rhinosinusitis (CRS) Diagnosis
Chronic Rhinosinusitis (CRS) is more than just a persistent cold; it is a clinical condition characterized by the inflammation of the sinus linings for 12 weeks or longer. According to medical guidelines from SinusHealth and other leading authorities, a diagnosis typically requires at least two major symptoms, such as nasal obstruction, thick discharge, facial pain, or a reduced sense of smell. To confirm the diagnosis, an ENT specialist will perform a nasal endoscopy or a CT scan to visualize the inflammation and potential blockages. Understanding the specific phenotype of your CRS—whether it occurs with or without nasal polyps—is the first step in determining the most effective course of treatment.2,3
Transitioning from Medical Management to Surgical Options
For many patients, the journey begins with conservative medical management, including saline irrigations, nasal steroid sprays, and courses of antibiotics. However, if these 'first-line' treatments fail to provide adequate relief, it may be time to consider a surgical procedure. This stage, known as the Procedure Decision phase, is where patients and surgeons evaluate the severity of the disease and structural obstructions. Surgery is often indicated when inflammation remains refractory to medication, or when physical obstructions like nasal polyps prevent topical treatments from reaching the deeper sinus tissues. Modern ENT technologies from Medtronic have significantly refined these interventions, making them safer and more precise than ever before.1,3
Functional Endoscopic Sinus Surgery (FESS): What to Expect
Functional Endoscopic Sinus Surgery (FESS) is the gold standard for treating extensive CRS. During this procedure, a surgeon uses a small, magnifying endoscope and specialized instruments to remove diseased tissue, bone, or polyps that are blocking the sinus ostia. The 'functional' aspect of the surgery focuses on restoring the natural drainage pathways of the sinuses while preserving as much healthy mucosa as possible. Because the entire procedure is performed through the nostrils, there are no external incisions or changes to the shape of the face. FESS is highly effective for patients with complex anatomy or severe inflammatory disease that requires a thorough opening of the sinus cavities.3,4
The Role of Propel™ Sinus Implants in Surgical Recovery
A critical advancement in the success of FESS is the use of the Medtronic Propel™ sinus implant. This bioabsorbable device is placed in the sinus cavity at the end of surgery to maintain the newly opened passage. Unlike traditional nasal packing, the Propel implant serves a dual purpose: it provides mechanical stenting to prevent the sinus from closing due to scarring, and it locally delivers a controlled dose of mometasone furoate—a potent anti-inflammatory steroid—directly to the healing tissue. Clinical studies have shown that the Propel implant reduces the need for additional surgical interventions and oral steroids by significantly decreasing post-operative inflammation and adhesion formation.6,7
Balloon Sinus Surgery (BSS) vs. Traditional Endoscopic Methods
When deciding on a procedure, patients may encounter Balloon Sinus Surgery (BSS), also known as balloon sinuplasty. This minimally invasive option involves a small balloon catheter that is inflated to expand the sinus openings without removing bone or tissue. While BSS offers a shorter recovery time—often just 24 to 48 hours—it may not be suitable for patients with severe nasal polyps or significant bone blockages. In contrast, FESS (often augmented with a Propel implant) is better suited for comprehensive disease clearance. Your surgeon will help you decide which approach is best based on your specific imaging and symptoms, ensuring the chosen method aligns with your long-term health goals.4,5
Post-Operative Milestones and Long-Term Success
Recovery from CRS procedures has been revolutionized by advanced technologies. Following a FESS procedure with a Propel implant, patients typically return to normal activities within a week. The Propel implant itself is designed to bio-absorb within 30 to 45 days, meaning no painful removal is required in the office. Long-term success is measured not just by the absence of symptoms, but by the restoration of a patient's quality of life. Ongoing care may still include saline rinses to keep the passages clear, but the primary goal of surgery is to ensure that future medical treatments can actually reach the sinus lining to prevent the recurrence of chronic inflammation.4,6
Frequently Asked Questions
Recovery time depends on the specific procedure performed. For minimally invasive options like balloon sinuplasty, patients often return to work within 1 to 2 days. For Functional Endoscopic Sinus Surgery (FESS), the typical recovery time is about one week. During this time, patients are encouraged to avoid heavy lifting and follow a strict regimen of saline irrigations. If your surgeon used a Propel sinus implant, the recovery may be smoother as the device continuously releases anti-inflammatory medication to reduce swelling and scarring, often leading to better healing outcomes and a reduced need for systemic oral steroids during the initial healing phase.4,5
The Propel sinus implant is not permanent; it is made from a bioabsorbable polymer designed to dissolve naturally within the body. It typically stays in place for about 30 to 45 days as it delivers its localized steroid medication (mometasone furoate) to the healing sinus lining. Because the material is bio-compatible and bio-absorbable, it does not require a secondary surgical procedure or a painful office visit for removal. This makes it a preferred option for patients looking for a more comfortable post-operative experience compared to traditional non-dissolvable nasal packing which must be pulled out by a physician.6,8
While surgery is highly effective at opening the sinus passages and removing blockages like polyps, CRS is a chronic inflammatory condition. This means that while the surgery addresses the physical obstruction, the underlying inflammatory process can occasionally persist. However, the use of advanced surgical techniques and technologies like the Propel implant significantly reduces the risk of 'recurrence' by preventing the formation of scar tissue and adhesions that could otherwise close the sinuses back up. Following surgery, most patients experience a dramatic, long-term improvement in their quality of life and better responses to ongoing medical management like saline rinses.2,3
The Propel implant offers three primary clinical benefits: it maintains the patency (openness) of the sinus cavity by providing structural support, it reduces inflammation through the targeted delivery of a corticosteroid, and it minimizes the need for oral steroids which can have systemic side effects like weight gain or mood changes. By delivering medication directly to the source of the inflammation for up to 60 days, the implant ensures that the sinuses heal in an 'open' state. Clinical data supported by Medtronic indicates that patients who receive the Propel implant have significantly lower rates of adhesion formation and surgical revision compared to those who do not.6,7,9
No, standard procedures for Chronic Rhinosinusitis, such as Functional Endoscopic Sinus Surgery (FESS) and Balloon Sinuplasty, do not change the outward appearance of the nose. These procedures are performed entirely 'endonasally,' meaning the surgeon works through the nostrils using small cameras and instruments. There are no external incisions on the face or bridge of the nose. The focus of the surgery is strictly on the internal sinus cavities and the drainage pathways. Therefore, patients can expect their facial features to remain exactly the same while the internal symptoms like congestion and pressure are significantly relieved.3,4
Important Safety Information
The PROPEL Family of sinus implants are indicated to deliver a steroid drug locally and maintain the sinus opening after sinus surgery in patients 18 years of age or older: PROPEL in the ethmoid sinus, PROPEL Mini in the ethmoid sinus and frontal sinus opening and PROPEL Contour in the frontal and maxillary sinus openings.
Patients allergic to the drug (mometasone furoate) or ingredients of the implant should not receive PROPEL.
It is not known if the implant is safe and effective in women that are pregnant or nursing.
Common side effects include infection, headache, and nose bleeds.
Risks related to the implant include pain/pressure, movement of the implant (within or out of the sinus) and potential side effects of steroids.
For more information on the risks and benefits of PROPEL sinus implants, talk to your doctor or review the FDA approved labeling at www.manuals.medtronic.com.
Rx only.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
